Why Key Account Management Matters for a Successful Pharma Product Launch

Another is confusing account management with high-frequency sales activity. More calls do not necessarily create better relationships.

A third problem is fragmented ownership. If multiple internal teams maintain different versions of the account strategy, the customer experience can become inconsistent.

Finally, some organizations fail to define what success actually means. Without measurable objectives, KAM can become a collection of meetings and account plans that produce little commercial value.

Selecting a KAM Consulting Partner

When evaluating providers, pharma companies should look for several capabilities.

Healthcare account expertise: The partner should understand complex US healthcare organizations.

Cross-functional experience: KAM cannot operate effectively if the provider understands only sales.

Analytics capability: Account prioritization should be evidence-based rather than driven solely by intuition.

Change-management expertise: New account models require adoption by internal teams.

Execution capability: The provider should be able to help move from account strategy to operational execution.

The Bottom Line

A successful pharmaceutical launch depends on more than product differentiation. It depends on whether the healthcare organizations that influence access and adoption are prepared to support the therapy.